Y. Mikami

PROFILE

Homepage
No homepage is listed.
ORCID
No ORCID is listed.
Affiliations
No affiliations are listed.
Aliases
Y Mikami, Yohei Mikami
Publication record
175 papers · 5,879 citations · H-index 38

PAPERS

Underestimation of the horizontal extent of ulcerative colitis-associated neoplasia may lead to incomplete endoscopic resection and subsequent recurrence
20260 citationsauthor #12
Efficacy and safety of mirikizumab in maintenance therapy for ulcerative colitis in difficult-to-treat inflammatory bowel disease: a single-center retrospective study in Japan.
20260 citationsauthor #7
Sa1932: SUGAR PREFERENCE-INDUCING BACTERIA SUPPRESS THE UNINTENTIONAL INTAKE OF ARTIFICIAL SWEETENERS
20250 citationsauthor #8
Adjustment of Surveillance Intervals for Ulcerative Colitis‐Associated Neoplasia Based on Disease Duration
20253 citationsauthor #13
Small Intestinal Stricture with Intense 18F-FDG PET Activity Caused By Endometriosis.
20250 citationsauthor #2
IL-17A inhibitor-induced pouchitis.
20250 citationsauthor #2
Identification and replication of sex-dimorphic protein quantitative trait loci across multiple ancestries and their associations with diseases
20251 citationsauthor #18
Leucine-rich alpha-2 glycoprotein in combination with C-reactive protein for predicting endoscopic activity in Crohn’s disease: a single-centre, cross-sectional study
20254 citationsauthor #3
Evaluation of Serum Leucine-Rich Alpha-2 Glycoprotein Levels in Inflammatory Bowel Disease Patients across Racial Groups
20250 citationsauthor #7
Gut Microbiota and Interorgan Communication Among the Gut, Brain, and Beyond
20250 citationsauthor #5
Sa1928: UPPER SMALL INTESTINAL MICROBIOTA CONTROLS HOST SUGAR PREFERENCE
20250 citationsauthor #6
Mo1694: VAGAL AGEING AND ITS POSSIBLE INVOLVEMENT IN HOMOEOSTATIC DISINTEGRATION
20250 citationsauthor #7
Mo1702: REGULATION OF INTESTINAL IMMUNITY VIA GUT-LIVER-BRAIN AXIS: A NOVEL VAGAL HEPATIC NERVE STIMULATION APPROACH FOR ENHANCING REGULATORY T CELLS
20250 citationsauthor #6
Factors Contributing to the Efficacy of Fecal Microbiota Transplantation for Diarrhea-Dominant Functional Bowel Disorders
20251 citationsauthor #8
The gut-organ axis: Clinical aspects and immune mechanisms.
202510 citationsauthor #7
First-line biologics as a treatment for ulcerative colitis: a multicenter randomized control study
20256 citationsauthor #51
Maternal circadian rhythms during pregnancy dictate metabolic plasticity in offspring
202510 citationsauthor #22
Efficacy of Dose Escalation of Oral 5-Aminosalicylic Acid for Ulcerative Colitis With a Mayo Endoscopic Subscore of 1: An Open Label Randomized Controlled Trial
20242 citationsauthor #9
176 INTER-ORGAN TRANSCRIPTOME HETEROGENEITY OF FIBROBLASTS IN THE GASTROINTESTINAL TRACT REVEALS POTENTIAL MECHANISMS UNDERLYING OESOPHAGEAL STRICTURE.
20240 citationsauthor #7
Video capsule endoscopy in overt and occult obscure gastrointestinal bleeding: Insights from a single‐center, observational study in Japan
20243 citationsauthor #10
Ulcerative colitis-associated neoplasms often harbor poor prognostic histologic components with low detection by biopsy
20242 citationsauthor #13
Correction: Association of ulcerative colitis symptom severity and proctocolectomy with multidimensional patient-reported outcomes: a cross-sectional study
20240 citationsauthor #6
Tu1115 CLINICAL CHARACTERISTICS AND IMPACT ON DAILY LIFE IN JAPANESE CROHN'S DISEASE PATIENTS: A MULTICENTER REGISTRY STUDY.
20240 citationsauthor #1
USEFULNESS OF UNDERWATER ENDOSCOPIC MUCOSAL RESECTION FOR SPORADIC NEOPLASM IN ULCERATIVE COLITIS
20240 citationsauthor #19
Su1796 POST-MARKETING SURVEILLANCE OF TOFACITINIB IN PATIENTS WITH ULCERATIVE COLITIS IN JAPAN: A FINAL REPORT OF SAFETY AND EFFECTIVENESS DATA
20240 citationsauthor #7
Tu1192 LYSIL OXYDASE INHIBITOR AMELIORATES THE INTESTINAL FIBROSIS: NOVEL TREATMENT FOR INTESTINAL FIBROSIS OF CROHN'S DISEASE.
20240 citationsauthor #8
A CTCF-binding site in the Mdm1-Il22-Ifng locus shapes cytokine expression profiles and plays a critical role in early Th1 cell fate specification.
202412 citationsauthor #19
Clinical outcomes of patients with remitting ulcerative colitis after discontinuation of indigo naturalis
20246 citationsauthor #12
Microbial ligand-independent regulation of lymphopoiesis by NOD1
20232 citationsauthor #7
The gut microbiota-induced kynurenic acid recruits GPR35-positive macrophages to promote experimental encephalitis.
202340 citationsauthor #16
Association of ulcerative colitis symptom severity and proctocolectomy with multidimensional patient-reported outcomes: a cross-sectional study
202310 citationsauthor #6
Myeloid TLR4 signaling promotes post-injury withdrawal resolution of murine liver fibrosis
202311 citationsauthor #5
Correction: Characteristics of adult patients newly diagnosed with Crohn’s disease: interim analysis of the nation-wide inception cohort registry study of patients with Crohn’s disease in Japan (iCREST-CD)
20231 citationsauthor #11
Enrichement of type I interferon signalling in the colonic ILC2 under inflammatory condition
20230 citationsauthor #1
Risk of venous thromboembolism with a central venous catheter in hospitalized Japanese patients with inflammatory bowel disease: a propensity score-matched cohort study
20234 citationsauthor #3
Characteristics of flat‐type ulcerative colitis‐associated neoplasia on chromoendoscopic imaging with indigo carmine dye spraying
20237 citationsauthor #6
P418 Dose escalation of oral 5-aminosalicylic acid for ulcerative colitis with Mayo endoscopic subscore of one improves long-term prognosis: a one-year multicentre, open-label, randomized controlled trial
20230 citationsauthor #9
D-amino Acids Ameliorate Experimental Colitis and Cholangitis by Inhibiting Growth of Proteobacteria: Potential Therapeutic Role in Inflammatory Bowel Disease
202339 citationsauthor #17
Safety and Effectiveness of Vedolizumab in Patients with Moderate-to-Severe Ulcerative Colitis: An Interim Analysis of a Japanese Post-Marketing Surveillance Study
20232 citationsauthor #3
Bacteriophage therapy against pathological Klebsiella pneumoniae that determine the clinical course of primary sclerosing cholangitis
20231 citationsauthor #27
Divergent roles for STAT4 in shaping differentiation of cytotoxic ILC1 and NK cells during gut inflammation
20239 citationsauthor #13
Bacteriophage therapy against pathological Klebsiella pneumoniae ameliorates the course of primary sclerosing cholangitis
202380 citationsauthor #31
Diagnosis and Clinical Features of Perianal Lesions in Newly Diagnosed Crohn’s Disease: Subgroup Analysis from Inception Cohort Registry Study of Patients with Crohn’s Disease (iCREST-CD)
202328 citationsauthor #14
P775 Disease activity and treatment patterns of newly diagnosed adult patients with Crohn's disease in Japan: Interim analysis of inception cohort registry study of patients with Crohn's disease (iCREST-CD)
20231 citationsauthor #12
Downregulation of chemokine receptor 9 facilitates CD4+CD8αα+ intraepithelial lymphocyte development
20234 citationsauthor #13
Correction to: Expert consensus on vaccination in patients with inflammatory bowel disease in Japan
20230 citationsauthor #28
Expert consensus on vaccination in patients with inflammatory bowel disease in Japan
20235 citationsauthor #28
IL-15-producing splenic B cells play pathogenic roles in the development of autoimmune hepatitis
20233 citationsauthor #9
Network Approaches to Uncover Pathogenesis and Therapeutic Targets of Inflammatory Bowel Diseases.
20232 citationsauthor #1
Intracellular metabolic adaptation of intraepithelial CD4+CD8αα+ T lymphocytes
202216 citationsauthor #9
Efficacy of Calcineurin Inhibitors for Induction of Remission in Intestinal Behçet’s Disease
20225 citationsauthor #8
Effectiveness and Durability of Ustekinumab Therapy With or Without Immunomodulators for Ulcerative Colitis Patients in Japan
20223 citationsauthor #9
Significance of 5-Aminosalicylic Acid Intolerance in the Clinical Management of Ulcerative Colitis
202258 citationsauthor #1
Enrichment of type I interferon signaling in colonic group 2 innate lymphoid cells in experimental colitis
20223 citationsauthor #19
Characteristics of adult patients newly diagnosed with Crohn’s disease: interim analysis of the nation-wide inception cohort registry study of patients with Crohn’s disease in Japan (iCREST-CD)
202224 citationsauthor #11
Differential Requirement of 3D Genomic Organization for the Mdm1-Il22-Ifng Locus Regulation in Adaptive Versus Innate Responses
20220 citationsauthor #16
A second update on mapping the human genetic architecture of COVID-19
202279 citationsauthor #3086
A case of a protuberant lesion on the Bauhin valve that was difficult to diagnose preoperatively
20220 citationsauthor #7
Heterogeneity of ILC2s in the Intestine; Homeostasis and Pathology
202216 citationsauthor #4
Aryl hydrocarbon receptor signals in epithelial cells govern the recruitment and location of Helios+ Tregs in the gut.
202238 citationsauthor #11
Neuroimmune crosstalk in the gut and liver.
20226 citationsauthor #2
Single-cell transcriptomics of human gut T cells identifies cytotoxic CD4+CD8A+ T cells related to mouse CD4 cytotoxic T cells
202213 citationsauthor #15
Application of 4-Diethylaminobenzoic Acid N-Succinimidyl Ester and Its Deuterated Isotopologue as Derivatization Reagents to Quantitative Analysis of γ-Aminobutyric Acid in Serum by LC/ESI-MS/MS
20222 citationsauthor #1
Severe graft‐versus‐host disease‐like enterocolitis accompanied with cytomegalovirus‐reactivation in drug‐induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms
20226 citationsauthor #7
DOCK2 is involved in the host genetics and biology of severe COVID-19
202274 citationsauthor #9
Usefulness of Texture and Color Enhancement Imaging (TXI) in Assessing Mucosal Healing in Patients with Ulcerative Colitis.
202215 citationsauthor #12
Bacteriotherapy for inflammatory bowel disease
202124 citationsauthor #2
MicroRNA-directed pathway discovery elucidates an miR-221/222–mediated regulatory circuit in class switch recombination
202112 citationsauthor #2
Bacteriotherapy for inflammatory bowel disease
20210 citationsauthor #2
Granzyme A and CD160 expression delineates ILC1 with graded functions in the mouse liver
202136 citationsauthor #20
Japan COVID-19 Task Force: a nation-wide consortium to elucidate host genetics of COVID-19 pandemic in Japan
202118 citationsauthor #39
Epithelium Replacement Contributes to Field Expansion of Squamous Epithelium and Ulcerative Colitis-Associated Neoplasia.
20217 citationsauthor #15
Application of the Jet Pump to the Slim Hole Production Wells at Onshore Thailand
20210 citationsauthor #3
MicroRNA-221 and -222 modulate intestinal inflammatory Th17 cell response as negative feedback regulators downstream of interleukin-23.
202148 citationsauthor #1
P172 Clinical characteristics of newly diagnosed adult patients with Crohn’s disease in Japan: Interim analysis of Inception cohort registry study of patients with Crohn’s disease (iCREST-CD)
20210 citationsauthor #11
Mapping the human genetic architecture of COVID-19
2021797 citationsauthor #1400
Predictors of necessity for endoscopic balloon dilatation in patients with Crohn’s disease-related small bowel stenosis
20212 citationsauthor #8
Hepatic Adenosine Triphosphate Reduction Through the Short‐Chain Fatty Acids–Peroxisome Proliferator‐Activated Receptor γ–Uncoupling Protein 2 Axis Alleviates Immune‐Mediated Acute Hepatitis in Inulin‐Supplemented Mice
202116 citationsauthor #6
CD8+ tissue-resident memory T cells promote liver fibrosis resolution by inducing apoptosis of hepatic stellate cells
2021167 citationsauthor #5
Circadian rhythms in the tissue-specificity from metabolism to immunity; insights from omics studies.
202122 citationsauthor #2
Pathogenesis and management of gastrointestinal inflammation and fibrosis: from inflammatory bowel diseases to endoscopic surgery
202111 citationsauthor #2
Vagus nerve-mediated intestinal immune regulation: therapeutic implications for inflammatory bowel diseases.
202138 citationsauthor #1
Organ and brain crosstalk: The liver-brain axis in gastrointestinal, liver, and pancreatic diseases.
202183 citationsauthor #4
Plasmacytoid dendrtic cells protect against acute liver injury via IL-35
20200 citationsauthor #5
The liver–brain–gut neural arc maintains the Treg cell niche in the gut
2020210 citationsauthor #2
Rapid Enhancer Remodeling and Transcription Factor Repurposing Enable High Magnitude Gene Induction upon Acute Activation of NK Cells.
202052 citationsauthor #2
Environmental arginine controls multinuclear giant cell metabolism and formation
202058 citationsauthor #15
New classification of CD4+CD8a+ double positive cells in Crohn’s disease patients
20200 citationsauthor #9
Significance of endoscopic deep small bowel evaluation using balloon-assisted enteroscopy for Crohn’s disease in clinical remission
202019 citationsauthor #7
5-Aminosalicylic acid intolerance is associated with a risk of adverse clinical outcomes and dysbiosis in patients with ulcerative colitis
202037 citationsauthor #3
The herbal medicine ‘Indigo naturalis’ altered gut microbiota to accumulate IL-22+ ILC3s
20200 citationsauthor #4
Mucosal concentrations of N‐acetyl‐5‐aminosalicylic acid related to endoscopic activity in ulcerative colitis patients with mesalamine
202015 citationsauthor #11
P630 Complete endoscopic remission is not only associated with higher mucosal concentrations of 5-aminosalicylic acid but also with N-acetyl-5-aminosalicylic acid in patients with ulcerative colitis
20201 citationsauthor #11
P093 The Comparison of Short-Term Efficacy of Treatments Between Tofacitinib and Vedolizumab in Patients With Ulcerative Colitis
20192 citationsauthor #5
Development of an Indigo Naturalis Suppository for Topical Induction Therapy in Patients with Ulcerative Colitis
201920 citationsauthor #13
Primary granulocytic sarcoma of the small intestine diagnosed by single‐balloon enteroscopy: A case report
20191 citationsauthor #2
Neuropeptide CGRP Limits Group 2 Innate Lymphoid Cell Responses and Constrains Type 2 Inflammation.
2019251 citationsauthor #9
Su1398 CLINICAL UTILITY OF BALLOON ASSISTED ENTEROSCOPY TO EVALUATE DEEP SMALL BOWEL LESIONS OF CROHN'S DISEASE
20190 citationsauthor #9
A case report of severe amoebic pancolitis with wide range of ulcerative lesion
20190 citationsauthor #9
Retinoic Acid Receptor Alpha Represses a Th9 Transcriptional and Epigenomic Program to Reduce Allergic Pathology
201964 citationsauthor #10

TIMELINE

2005 0 citations

2009 22 citations

2010 223 citations

2011 51 citations

2012 318 citations

2013 725 citations

2014 139 citations

2015 277 citations

2016 436 citations

2017 298 citations

2018 648 citations

2019 412 citations

2020 392 citations

2021 1,281 citations

2022 358 citations

2023 249 citations

2024 25 citations

2025 35 citations

2026 0 citations

Y. Mikami

PROFILE

PAPERS

TIMELINE

COAUTHOR MAP

CONCEPT FOOTPRINT